Creative Medical Launching StemSpine Stem Cell Treatment in the U.S.

Creative Medical Technology (CMT) will commence commercialization of StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease, in the U.S. in coming weeks. The procedure has been employed successfully ex-U.S. with over 12 months of data showing safety and efficacy.

The patented procedure offers a drug-free...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us